Istanbul University, Istanbul Faculty of Medicine, Department of Medical Microbiology, Istanbul, Turkey.
Istanbul University, Istanbul Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Istanbul, Turkey.
Rev Argent Microbiol. 2020 Oct-Dec;52(4):266-271. doi: 10.1016/j.ram.2020.01.002. Epub 2020 Mar 13.
Syphilis has become a serious issue for human immunodeficiency virus (HIV)-infected patients worldwide in recent years; however, the studies related to HIV coinfection and syphilis reinfections in Istanbul, Turkey, are limited. Our objective was to determine the seroprevalence of syphilis among HIV-infected men in the city which has one of the highest HIV prevalence rates in Turkey. Two hundred and forty four (244) HIV-positive men were evaluated at Istanbul Medical Faculty, Department of Medical Microbiology from March to June 2018. Serum samples were screened for the presence of antibodies against Treponema pallidum using the chemiluminescent microparticle immunoassay (CMIA). Samples found to be positive were investigated with the rapid plasma reagin (RPR) test and the T. pallidum hemagglutination assay (TPHA). The patients completed a questionnaire for sociodemographic data. The mean age was found to be 41.8 years; 35.6% were men who have sex with men (MSM). The overall seroprevalence of syphilis among the patients was 19.3%. MSM had a significantly higher seroprevalence than heterosexual patients (28.7%). In Turkey, there is a high seroprevalence of syphilis in HIV-infected patients, MSM being the most affected group. Therefore, HIV-infected patients should be screened for syphilis at least annually and should be informed about sexually transmitted diseases (STDs).
近年来,梅毒已成为全球人类免疫缺陷病毒(HIV)感染者的一个严重问题;然而,关于土耳其伊斯坦布尔 HIV 合并感染和梅毒再感染的研究有限。我们的目的是确定该市 HIV 感染者中梅毒的血清流行率,该市是土耳其 HIV 感染率最高的城市之一。2018 年 3 月至 6 月,在伊斯坦布尔医学系医学微生物学系评估了 244 名 HIV 阳性男性。使用化学发光微粒子免疫分析(CMIA)检测血清样本中针对梅毒螺旋体的抗体。发现阳性样本用快速血浆反应素(RPR)试验和梅毒螺旋体血凝试验(TPHA)进行调查。患者完成了一份社会人口统计学数据的问卷。平均年龄为 41.8 岁;35.6%为男男性接触者(MSM)。患者中梅毒的总血清流行率为 19.3%。MSM 的血清流行率明显高于异性恋患者(28.7%)。在土耳其,HIV 感染者的梅毒血清流行率很高,MSM 是受影响最大的群体。因此,HIV 感染者应至少每年筛查梅毒,并应告知其有关性传播疾病(STD)的信息。